REPORT DESCRIPTION
Peptide Therapeutics Market – Overview
The global peptide therapeutics market size was valued at US$ 22,071.5 Mn in 2017 and is expected to
witness a CAGR of 9.1% over the forecast period (2018 – 2026).
Peptide are selective efficacious signaling molecules, which bind to specific cell surface receptors such as
G Protein-Coupled Receptors (GPCRs) or ion channels, where they trigger intracellular effects. More than
7000 naturally occurring peptides have been identified, which have role in human physiology including
functions such as neurotransmitters, hormones, growth factors, ion channel ligands, and anti-infective.
Peptides are efficient precursors in designing of novel therapeutics, owing to their specificity, safety,
tolerability intrinsic properties and its ability to provide expected results in humans. According to the
Bioorganic & Medicinal Chemistry Journal, June 2018, around 60 peptide drugs are approved in the U.S.
and in other major markets, such as Europe, and Japan.